Article

Dr. Joshua Lenchus Addresses the Challenge of Bias in Health Care

Joshua D. Lenchus, DO, RPh, FACP, FHM, discusses the lack of impact comparative effectiveness research (CER) has had on patient safety. In addition, he speaks about the need for more comparisons that study safety and efficacy in patient populations.

Joshua D. Lenchus, DO, RPh, FACP, FHM, discusses the lack of impact comparative effectiveness research (CER) has had on patient safety. In addition, he speaks about the need for more comparisons that study safety and efficacy in patient populations. There are asymmetries which need to be overcome in the delivery of information between industry and government.

Dr. Lenchus believes regulations on industry need to be loosened and must be on par with the regulations that will guide the government’s interactions with CER.

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Mabel Mardones, MD.
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo